相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Skin biopsy Biopsy issues in specific diseases
Dirk M. Elston et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Risk of cutaneous toxicities in patients with solid tumors treated with immune checkpoint inhibitors: a meta-analysis
Omar Abdel-Rahman et al.
FUTURE ONCOLOGY (2015)
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Jeffrey S. Weber et al.
LANCET ONCOLOGY (2015)
Acute skin reaction suggestive of pembrolizumab-induced radiosensitization
Vincent Sibaud et al.
MELANOMA RESEARCH (2015)
A case of bullous pemphigoid in a patient with metastatic melanoma treated with pembrolizumab
Giuliana Carlos et al.
MELANOMA RESEARCH (2015)
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
Martina Sanlorenzo et al.
JAMA DERMATOLOGY (2015)
Immune Checkpoint Blockade in Cancer Treatment: A Double-Edged Sword Cross-Targeting the Host as an Innocent Bystander
Lucia Gelao et al.
TOXINS (2014)
Bullous pemphigoid: Associations and management guidelines: Facts and controversies
Eleonora Ruocco et al.
CLINICS IN DERMATOLOGY (2013)
Bullous pemphigoid: Etiology, pathogenesis, and inducing factors: Facts and controversies
Ada Lo Schiavo et al.
CLINICS IN DERMATOLOGY (2013)
Safety and Tumor Responses with Lambrolizumab (Anti-PD-1) in Melanoma
Omid Hamid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
分享论文
